Mohammad Ramezani

654 total citations
18 papers, 505 citations indexed

About

Mohammad Ramezani is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Mohammad Ramezani has authored 18 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Biomaterials and 8 papers in Biomedical Engineering. Recurrent topics in Mohammad Ramezani's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Mohammad Ramezani is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Mohammad Ramezani collaborates with scholars based in Iran, United States and Czechia. Mohammad Ramezani's co-authors include Khalil Abnous, Seyed Mohammad Taghdisi, Mona Alibolandi, Mahsa Shahriari, Mahsa Zahiri, Mona Alibolandi, Farzin Hadizadeh, Sadegh Dehghani, Hossein Hosseinzadeh and Ali Samie and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Mohammad Ramezani

17 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Ramezani Iran 7 291 258 210 70 49 18 505
Mahsa Shahriari Iran 5 286 1.0× 240 0.9× 188 0.9× 62 0.9× 54 1.1× 6 465
Mahsa Zahiri Iran 11 374 1.3× 365 1.4× 253 1.2× 106 1.5× 49 1.0× 15 654
Guanqing Yang China 12 256 0.9× 245 0.9× 155 0.7× 80 1.1× 35 0.7× 17 498
Die Jia China 13 310 1.1× 377 1.5× 170 0.8× 126 1.8× 59 1.2× 14 595
Shiqi Hu China 11 261 0.9× 272 1.1× 236 1.1× 112 1.6× 65 1.3× 19 601
Chengyue Guo China 9 304 1.0× 319 1.2× 219 1.0× 101 1.4× 41 0.8× 13 604
Hussaini Syed Sha Qhattal United States 5 259 0.9× 183 0.7× 260 1.2× 46 0.7× 40 0.8× 5 558
Fabiola Porta Switzerland 11 234 0.8× 163 0.6× 125 0.6× 123 1.8× 80 1.6× 17 443

Countries citing papers authored by Mohammad Ramezani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Ramezani more than expected).

Fields of papers citing papers by Mohammad Ramezani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Ramezani. The network helps show where Mohammad Ramezani may publish in the future.

Co-authorship network of co-authors of Mohammad Ramezani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Ramezani. A scholar is included among the top collaborators of Mohammad Ramezani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Ramezani. Mohammad Ramezani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Samie, Ali, et al.. (2025). Targeted delivery of doxorubicin toward 4 T1 cells via in situ binding between maleimide functionalized AS1411 − NH2 aptamer and endogenous albumin. International Journal of Biological Macromolecules. 318(Pt 3). 145236–145236. 1 indexed citations
3.
Taghdisi, Seyed Mohammad, Roozbeh Ghaffari, Mona Alibolandi, et al.. (2025). Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases. MedComm. 6(5). e70180–e70180. 1 indexed citations
4.
Taghdisi, Seyed Mohammad, Ali Samie, Morteza Alinezhad Nameghi, et al.. (2024). Surface modification of hollow gold nanoparticles conducted by incorporating cancer cell membrane and AS1411 aptamer, aiming to achieve a dual-targeted therapy for colorectal cancer. International Journal of Pharmaceutics. 655. 124036–124036. 20 indexed citations
5.
Alibolandi, Mona, et al.. (2024). A four in one nanoplatform: Theranostic bismuth-containing nanoMOFs for chemo-photodynamic- radiation therapy and CT scan imaging. International Journal of Pharmaceutics. 668. 124971–124971. 1 indexed citations
6.
Zahiri, Mahsa, Khalil Abnous, Seyed Mohammad Taghdisi, et al.. (2024). Nucleolin-targeted doxorubicin and ICG co-loaded theranostic lipopolymersome for photothermal-chemotherapy of melanoma in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 202. 114411–114411. 6 indexed citations
7.
Hadizadeh, Farzin, Mona Alibolandi, Mohammad Ramezani, et al.. (2024). Targeted delivery of SN38 to breast cancer using amphiphilic diblock copolymers PHPMA-b-PBAEM as micellar carriers with AS1411 aptamer. International Journal of Pharmaceutics. 661. 124387–124387. 2 indexed citations
8.
Abnous, Khalil, et al.. (2024). Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma. Nanomedicine Nanotechnology Biology and Medicine. 62. 102778–102778. 2 indexed citations
9.
Dehghani, Sadegh, Hossein Hosseinzadeh, Khalil Abnous, et al.. (2024). An exosomal approach for oral delivery of resveratrol: Implications for inflammatory bowel disease treatment in rat model. Life Sciences. 346. 122638–122638. 11 indexed citations
10.
Ramezani, Mohammad, et al.. (2024). Synthesis of theranostic aptamer targeted polydopamine-coated gold nanocages for chemo-photothermal therapy against melanoma. Journal of Drug Delivery Science and Technology. 103. 106443–106443. 5 indexed citations
11.
Taghavi, Sahar, Khalil Abnous, Seyed Mohammad Taghdisi, et al.. (2024). Targeted doxorubicin-loaded core–shell copper peroxide-mesoporous silica nanoparticles for combination of ferroptosis and chemotherapy of metastatic breast cancer. International Journal of Pharmaceutics. 662. 124487–124487. 6 indexed citations
12.
13.
Dehghani, Sadegh, Sahar Taghavi, Seyed Mohammad Taghdisi, et al.. (2024). Synthesis of a Smart pH Sensitive Micelle Containing Hyaluronic Acid-Curcumin Bioconjugate Against Colorectal Cancer. BioNanoScience. 15(1). 3 indexed citations
14.
Behnam, Behzad, Ahad Mokhtarzadeh, Ramin Rezaee, et al.. (2023). Reproductive Toxicity of Nanoparticles: A Comprehensive Review. Current Medicinal Chemistry. 32(8). 1507–1552. 5 indexed citations
15.
Shahriari, Mahsa, Khalil Abnous, Farzin Hadizadeh, et al.. (2021). Design and synthesis of targeted star-shaped micelle for guided delivery of camptothecin: In vitro and in vivo evaluation. Materials Science and Engineering C. 131. 112529–112529. 18 indexed citations
16.
Shahriari, Mahsa, Seyed Mohammad Taghdisi, Khalil Abnous, Mohammad Ramezani, & Mona Alibolandi. (2021). Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer. Journal of Controlled Release. 335. 369–388. 52 indexed citations
17.
Shahriari, Mahsa, Mahsa Zahiri, Khalil Abnous, et al.. (2019). Enzyme responsive drug delivery systems in cancer treatment. Journal of Controlled Release. 308. 172–189. 318 indexed citations
18.
Shahriari, Mahsa, Seyed Mohammad Taghdisi, Khalil Abnous, Mohammad Ramezani, & Mona Alibolandi. (2019). Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer. International Journal of Pharmaceutics. 572. 118835–118835. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahsa Shahriari Breakdown of academic impact, for papers by Mahsa Zahiri Breakdown of academic impact, for papers by Guanqing Yang Breakdown of academic impact, for papers by Die Jia Breakdown of academic impact, for papers by Shiqi Hu Breakdown of academic impact, for papers by Chengyue Guo Breakdown of academic impact, for papers by Hussaini Syed Sha Qhattal Breakdown of academic impact, for papers by Fabiola Porta
Rankless by CCL
2026